S.M. Goldinger

Type de document

Articles (4)

Co-auteur

Date

Source

Mot-clé

Patients (4) Melanoma (4) Patients (4) maladie (3) survie (3) Theater (3) Survival (3) Months (3) Human beings (3) Drama (3) Acting (3) maladie (3) thérapie (2) peau (2) analyse (2) procès (2) taux (2) Treatment (2) Inhibitors (2) Therapeutics (2) Skin (2) Immunoglobulins (2) December (2) Older people (2) Use (2) Analysis (2) toxicité (1) norme (1) étable (1) spectacle (1)

Documents écrit par S.M. Goldinger (4) | parle de S.M. Goldinger (0)

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.
J. Mangana et al.
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
J. Mangana et al. (2015)
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07).
R. von Moos et al. (2012)
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.
S.M. Goldinger et al. (2012)